These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21054664)

  • 21. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TaqMan amplification system with an internal positive control for HCV RNA quantitation.
    Castelain S; Descamps V; Thibault V; François C; Bonte D; Morel V; Izopet J; Capron D; Zawadzki P; Duverlie G
    J Clin Virol; 2004 Nov; 31(3):227-34. PubMed ID: 15465417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients.
    Medhi S; Potukuchi SK; Polipalli SK; Swargiary SS; Deka P; Chaudhary A; Begum N; Hussain Z; Ahlawat RS; Kar P
    Clin Biochem; 2008 May; 41(7-8):447-52. PubMed ID: 18267117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use and interpretation of virological tests for hepatitis C.
    Pawlotsky JM
    Hepatology; 2002 Nov; 36(5 Suppl 1):S65-73. PubMed ID: 12407578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.
    Nakamura H; Ogawa H; Kuroda T; Yamamoto M; Enomoto H; Kishima Y; Yoshida K; Ito H; Matsuda M; Noguchi S
    Hepatogastroenterology; 2002; 49(47):1373-6. PubMed ID: 12239945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of the efficacy of antiviral therapy for hepatitis C virus infection by an ultrasensitive RT-PCR assay.
    Kinai E; Hanabusa H; Kato S
    J Med Virol; 2007 Aug; 79(8):1113-9. PubMed ID: 17596840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes.
    Chevaliez S; Pawlotsky JM
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1031-48. PubMed ID: 19187865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing strategies for hepatitis C testing.
    Teo CG
    Antivir Ther; 2012; 17(7 Pt B):1391-5. PubMed ID: 23322655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of a commercial quantitative hepatitis C virus core antigen assay in a diagnostic laboratory setting.
    Ergünay K; Sener B; Alp A; Karakaya J; Hasçelik G
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):486-91. PubMed ID: 21767705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus infection management in 2012.
    Van Gulick JJ; Lamers MH; Drenth JP
    Panminerva Med; 2012 Mar; 54(1):1-9. PubMed ID: 22278112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HCV RNA viral load assessments in the era of direct-acting antivirals.
    Cobb B; Pockros PJ; Vilchez RA; Vierling JM
    Am J Gastroenterol; 2013 Apr; 108(4):471-5. PubMed ID: 23552304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus: virology, diagnosis and management of antiviral therapy.
    Chevaliez S; Pawlotsky JM
    World J Gastroenterol; 2007 May; 13(17):2461-6. PubMed ID: 17552030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCV RNA quantification with different assays: implications for protease-inhibitor-based response-guided therapy.
    Fevery B; Susser S; Lenz O; Cloherty G; Perner D; Picchio G; Sarrazin C
    Antivir Ther; 2014; 19(6):559-67. PubMed ID: 24584086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virological tools for optimal management of chronic hepatitis C.
    Deltenre P
    Acta Gastroenterol Belg; 2009; 72(4):421-4. PubMed ID: 20163036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of HCV antigen test with reference to PCR in confirming infection in cases with indefinite antibody test result.
    Seiskari T; Horsti J; Aittoniemi J
    J Clin Virol; 2011 May; 51(1):90-1. PubMed ID: 21377410
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis C virus core antigen: A diagnostic and treatment monitoring marker of hepatitis C virus in Indian population.
    Garg J; Verma P; Singh M; Das A; Pathak A; Agarwal J
    Indian J Gastroenterol; 2024 Aug; 43(4):799-804. PubMed ID: 38619807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection limit of architect hepatitis C core antigen assay in correlation with HCV RNA, and renewed confirmation algorithm for reactive anti-HCV samples.
    Ottiger C; Gygli N; Huber AR
    J Clin Virol; 2013 Nov; 58(3):535-40. PubMed ID: 24041472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C core Ag and its clinical applicability: potential advantages and disadvantages for diagnosis and follow-up?
    Hosseini-Moghaddam SM; Iran-Pour E; Rotstein C; Husain S; Lilly L; Renner E; Mazzulli T
    Rev Med Virol; 2012 May; 22(3):156-65. PubMed ID: 22121001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a hepatitis C virus (HCV) antigen assay for routine HCV screening among men who have sex with men infected with HIV.
    Vanhommerig JW; van de Laar TJ; Koot M; van Rooijen MS; Schinkel J; Speksnijder AG; Prins M; de Vries HJ; Bruisten SM
    J Virol Methods; 2015 Mar; 213():147-50. PubMed ID: 25528203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.